SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021579
Filing Date
2018-08-14
Accepted
2018-08-14 08:01:31
Documents
72
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atnx-10q_20180630.htm 10-Q 2688169
2 EX-10.7 atnx-ex107_47.htm EX-10.7 202155
3 EX-31.1 atnx-ex311_7.htm EX-31.1 18784
4 EX-31.2 atnx-ex312_6.htm EX-31.2 18282
5 EX-32.1 atnx-ex321_8.htm EX-32.1 9578
  Complete submission text file 0001564590-18-021579.txt   11084569

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atnx-20180630.xml EX-101.INS 3019322
7 XBRL TAXONOMY EXTENSION SCHEMA atnx-20180630.xsd EX-101.SCH 60387
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atnx-20180630_cal.xml EX-101.CAL 46462
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atnx-20180630_def.xml EX-101.DEF 226874
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20180630_lab.xml EX-101.LAB 457461
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20180630_pre.xml EX-101.PRE 371306
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38112 | Film No.: 181014352
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1